Latest Breaking News On - Bayer head - Page 2 : comparemela.com

GreenLight Biosciences Acquires Bayer's topical RNA Intellectual Property portfolio

GreenLight Biosciences Acquires Bayer s topical RNA Intellectual Property portfolio News provided by Share this article Share this article BOSTON, May 20, 2021 /PRNewswire/ GreenLight Biosciences today announced that they have acquired rights to portions of Bayer s topical RNA Intellectual Property portfolio. These assets include bee health capabilities to protect against Varroa mites, a major threat to honeybees. The RNA-based Varroa mite control advance allows beekeepers to directly target the Varroa mite without harming the honeybee, a critical advantage to other treatments on the market today. Honeybee with parasitic Varroa destructor mite RNA s potential for improving plant, animal, and human health has been known for years, but widespread commercial use hasn t previously been possible, due to RNA s cost of production and slow production time.

Kooperation mit Curevac: Bayer hilft bei Corona-Impfstoff